✦ LIBER ✦

AN UPDATE OF COMBINED MODALITY THERAPY FOR PATIENTS WITH MUSCLE INVADING BLADDER CANCER USING SELECTIVE BLADDER PRESERVATION OR CYSTECTOMY

✍ Scribed by SHIPLEY, WILLIAM U.; KAUFMAN, DONALD S.; HENEY, NIALL M.; ALTHAUSEN, ALEX F.; ZIETMAN, ANTHONY L.

Book ID: 122314202
Publisher: Lippincott Williams and Wilkins
Year: 1999
Tongue: English
Weight: 817 KB
Volume: 162
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)68582-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AN UPDATE OF COMBINED MODALITY THERAPY F

AN UPDATE OF COMBINED MODALITY THERAPY FOR PATIENTS WITH MUSCLE INVADING BLADDER CANCER USING SELECTIVE BLADDER PRESERVATION OR CYSTECTOMY

📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 190 KB

Opportunities with combined modality the

Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer

✍ Colvett, Kyle T.; Althausen, Alex F.; Bassil, Barbara; Heney, Niall M.; McGovern 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

Combined-modality therapy for organ preservation represents an appropriate alternative to radical surgery in the management of several malignant diseases. The standard therapy for muscle-invasive bladder cancer in the United States has been radical cystectomy. Although the sequelae of radical surger

Association of statin use with improved

Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer

✍ Henry K. Tsai; Matthew S. Katz; John J. Coen; Anthony L. Zietman; Donald S. Kauf 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Association of statin use with improved

Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer

✍ Andriole, G.L. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 53 KB

A PHASE I/II TRIAL OF TRANSURETHRAL SURG

A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER

✍ ZIETMAN, A.L.; SHIPLEY, W.U.; KAUFMAN, D.S.; ZEHR, E.M.; HENEY, N.M.; ALTHAUSEN, 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 650 KB

Phase I-II RTOG Study (99-06) of Patient

Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy

✍ Donald S. Kaufman; Kathryn A. Winter; William U. Shipley; Niall M. Heney; H. Jam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 396 KB